Related Experiment Video
Updated: Jun 26, 2026

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
Delayed Hemolysis With Parenteral Artesunate
Alfred Awuah1, Punit Jitendra Shah2, Farheen Tariq2
1Houston Methodist Hospital, Houston, TX, USA.
Abstract:
Artesunate is an effective and first-line therapy option in patients with severe malaria caused by Plasmodium species. Among adverse effects of the drug is a phenomenon of delayed hemolysis. This usually occurs at least 7 days after initiation of therapy, and is characterized by reductions in hemoglobin and haptoglobin and an increase in lactate dehydrogenase. Here, we report an instance of delayed hemolysis in a patient probably attributed to parenteral artesunate therapy.
Related Concept Videos
Malaria
Antiprotozoal Agents

